PreciseDx Secures $20.7M to Improve Diagnostics in Oncology Using AI Technology

PreciseDx Secures $20.7M to Improve Diagnostics in Oncology Using AI Technology

PreciseDx, a pioneering medical technology leveraging the power of artificial intelligence (AI) to improve diagnostics in oncology, has secured $20.7 million in a series B funding round to accelerate growth and expansion. Co-founded in 2020 by Jack Zeineh MD, and Gerardo Fernandez MD, the company’s latest financing round was spearheaded by Eventide Asset Management, supported by contributions from Quest Diagnostics, GenHenn Capital Venture, Labcorp, and existing investors. The new capital brings PreciseDx’s total funding to $31.5 million since its launch.

Please login to comment on this Post

Most Visited Posts

1

Education September 30, 2025

Explore AI Legal Certification Program Elevate Your Career

AI Legal Certification empowers you with advanced legal tech skills. Stay ahead, boost expertise, and drive career success. Join now. Learn how AI transforms law and gain expertise that sets you apart.

2

Health September 08, 2023

Alopecia Natural Treatments, The Role of Diet and Remedies

Investigate successful and Alopecia Natural Treatments with diet and remedies to encourage hair growth and stop hair loss.

3

Business September 12, 2023

Subscribe to James Peter Henry for Latest Updates

Subscribe to James Peter Henry and stay in the loop! Get the latest updates on custom murals, captivating fine art, and exclusive fashion collaborations. Dive into hisworld of artistry!